Drug Policy Alliance (DPA) explains the decriminalisation model in Oregon, its reversal after a misinformation campaign, and the costs and harms of recriminalisation.
Zoorob et al. reveal fentanyl as a large driver of the US overdose epidemic, whilst dispelling misconceptions about the effect of Oregon's drug decriminalisation policies on rises in mortality and overdose rates.
Rouhani et al. explore how US prosecutors use harm reduction principles to shape criminal justice outcomes for people who use drugs, revealing the potential for pro-drug policy reform.
Experts denounce catastrophic move that would slash safe supply programmes, consumption sites, or needle and syringe programs – all critical interventions.
Brown's overview urges government bodies to prioritise gender-sensitive care in harm reduction services, highlighting the need for targeted funding and support for women who use drugs.
Hedden-Claytone et al. explore the power of a harm reduction educational programme designed for people who supply drugs in mitigating drug-related harms.
Activists at DULF have spearheaded a life-saving intervention by distributing drugs of known content, igniting a crucial debate on the necessity of safer supply policies to prevent overdose fatalities.
De Shalit et al. conduct the first independent and national study of Canada's federal prison needle exchange program, determining that drug use stigma and anticipated or actual reprisal from correctional officers are preventing program uptake.
